Author: Michael Andersen

Off-Label Pharmaceutical Marketing Note Published

My Note, Bound Guidance: FDA Rulemaking for Off-Label Pharmaceutical Drug Marketing, has recently been published in volume 60 of the Case Western Reserve Law Review, pages 531-558.  The Note discusses an FDA guidance document that establishes when pharmaceutical companies can provide doctors with reprints of journal articles promoting off-label uses of their drugs.  It considers both the regulatory framework authorizing the FDA’s guidance, and the First Amendment rights triggered by the FDA’s attempt to restrict a company’s commercial speech.

Allowing doctors the freedom to prescribe drugs for a use other than the narrow purpose initially authorized by the FDA can unquestionably save lives. However, it is also essential to ensure that doctors have the information they need to make an informed decision before prescribing a drug for a purpose for which it was not originally intended.

Click here to download the Note.

MIT Mystery Hunt 2017 – Sample Videos

Live event from the 2017 MIT Mystery HuntQuizardry, a game of trivia where the answers are never what you would expect.

The 2017 MIT Mystery Hunt boss battle, playing out on a hexagonal board game.

Lucas Johnson on Definitional Debates

“ARG” is the sound that Lucas Johnson, Founder and CEO of Silverstring Media, makes when people get into definitional debates.

© 2019 ARGNet

Theme by Anders NorenUp ↑